ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,488.00
-0.25%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37725
-0.03%
Bitcoin
69,398.93
0.10%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oncocyte Corporation (OCX)

  7. Oncocyte Corporation (OCX) News

OCX

Oncocyte (OCX)

Oncocyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OCX
DateTimeSourceHeadlineSymbolCompany
06/04/20244:02PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
06/03/20241:13PMGlobeNewswire Inc.Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft StudyNASDAQ:OCXOncocyte Corporation
05/31/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
05/30/20243:47PMGlobeNewswire Inc.Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of MedicineNASDAQ:OCXOncocyte Corporation
05/23/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
05/23/202410:26AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
05/22/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
05/22/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
05/22/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
05/17/20244:11PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:OCXOncocyte Corporation
05/15/20243:05PMGlobeNewswire Inc.Oncocyte Reports First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
05/13/20247:00AMGlobeNewswire Inc.Oncocyte to Announce First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
05/10/20244:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
05/07/20248:19AMGlobeNewswire Inc.PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceNASDAQ:OCXOncocyte Corporation
04/12/20245:00AMGlobeNewswire Inc.Oncocyte Reports Full Year 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
04/11/20248:46PMGlobeNewswire Inc.Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesNASDAQ:OCXOncocyte Corporation
04/11/20244:30PMGlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNASDAQ:OCXOncocyte Corporation
04/09/20243:05PMGlobeNewswire Inc.Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
01/23/20243:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
01/16/20247:00AMGlobeNewswire Inc.Oncocyte to Present at the Sequire Investor Summit in Puerto RicoNASDAQ:OCXOncocyte Corporation
12/06/20237:00AMGlobeNewswire Inc.Oncocyte Begins FDA Submissions Process for VitaGraft Transplant AssaysNASDAQ:OCXOncocyte Corporation
11/09/20234:19PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
11/09/20236:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
11/09/20236:00AMGlobeNewswire Inc.Oncocyte Reports Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
11/03/20237:30AMGlobeNewswire Inc.Oncocyte to Announce Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
10/12/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
10/10/20233:48PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OCXOncocyte Corporation
10/05/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
09/20/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
08/28/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
 Showing the most relevant articles for your search:NASDAQ:OCX

Your Recent History

COIN
CCPPUST
CryptoCoinPay
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved